Cencora Company Insiders
COR Stock | USD 237.01 3.50 1.46% |
Slightly above 89 percent of Cencora's insiders are activelly selling. The analysis of insiders' sentiment of trading Cencora stock suggests that quite a large number of insiders are panicking at this time. Cencora employs about 46 K people. The company is managed by 36 executives with a total tenure of roughly 156 years, averaging almost 4.0 years of service per executive, having 1277.78 employees per reported executive.
Paul Szurek CEO President, Chief Executive Officer, Director |
Robert Stuckey Chairman Independent Chairman of the Board |
Cencora's Insider Buying Vs Selling
11
Selling | Buying |
Latest Trades
2024-11-25 | Steven H Collis | Disposed 50000 @ 243.97 | View | ||
2024-11-19 | Steven H Collis | Disposed 21509 @ 242.16 | View | ||
2024-10-22 | Steven H Collis | Disposed 21509 @ 235.8 | View | ||
2024-08-06 | Silvana Battaglia | Disposed 1473 @ 242.69 | View | ||
2024-08-01 | Walgreens Boots Alliance, Inc. | Disposed 4438171 @ 240.56 | View | ||
2024-07-16 | Steven H Collis | Disposed 10755 @ 222.12 | View | ||
2024-05-31 | Gina Clark | Disposed 1874 @ 223.86 | View | ||
2024-05-29 | Greg Landsman | Acquired @ 219.06 | |||
2024-05-24 | Dermot Mark Durcan | Acquired 500 @ 218.58 | View | ||
2024-05-22 | Walgreens Boots Alliance, Inc. | Disposed 1859390 @ 215.12 | View | ||
2024-04-16 | Steven H Collis | Disposed 10754 @ 237.48 | View | ||
2024-04-15 | Robert P Mauch | Disposed 57564 @ 235.09 | View | ||
2024-03-18 | Elizabeth S Campbell | Disposed 6977 @ 238.12 | View | ||
2024-02-13 | Gina Clark | Disposed 1100 @ 230.48 | View | ||
2024-02-07 | Walgreens Boots Alliance, Inc. | Disposed 4212395 @ 235.41 | View | ||
2023-12-21 | Leslie E Donato | Disposed 3400 @ 202.13 | View | ||
2023-12-12 | Steven H Collis | Disposed 25000 @ 202.15 | View |
Monitoring Cencora's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Acquired vs Disposed
Filed vs Not Filed
Insider sentiment refers to the collective sentiment or feeling of Cencora's insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of Cencora. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe Cencora's stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
Cencora |
Cencora's latest congressional trading
Congressional trading in companies like Cencora, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Cencora by those in governmental positions are based on the same information available to the general public.
2024-11-14 | Representative Michael McCaul | Acquired $15K to $50K | Verify | ||
2024-08-14 | Representative Greg Landsman | Acquired $15K to $50K | Verify | ||
2021-09-01 | Senator Thomas R Carper | Acquired Under $15K | Verify | ||
2021-08-31 | Senator Thomas R Carper | Acquired Under $15K | Verify |
Cencora Management Team Effectiveness
The company has Return on Asset of 0.031 % which means that on every $100 spent on assets, it made $0.031 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 2.0912 %, implying that it generated $2.0912 on every 100 dollars invested. Cencora's management efficiency ratios could be used to measure how well Cencora manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Cencora's Return On Tangible Assets are relatively stable compared to the past year. As of 12/11/2024, Return On Assets is likely to grow to 0.02, while Return On Capital Employed is likely to drop 0.15. At this time, Cencora's Return On Assets are relatively stable compared to the past year. As of 12/11/2024, Asset Turnover is likely to grow to 5.17, while Intangible Assets are likely to drop slightly above 2.7 B.Cencora Quarterly Income Before Tax |
|
Cencora Workforce Comparison
Cencora is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 146,007. Cencora totals roughly 46,000 in number of employees claiming about 32% of equities under Health Care industry.
Cencora Profit Margins
The company has Net Profit Margin of 0.01 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.01 %, which entails that for every 100 dollars of revenue, it generated $0.01 of operating income.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.0408 | 0.0337 |
|
|
Cencora Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cencora insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cencora's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Cencora insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-12-01 | 0.7255 | 37 | 51 | 414,887 | 384,435 |
2024-09-01 | 0.6364 | 7 | 11 | 44,784 | 4,532,645 |
2024-06-01 | 1.0 | 12 | 12 | 94,281 | 2,071,417 |
2024-03-01 | 1.75 | 21 | 12 | 60,140 | 4,259,746 |
2021-12-01 | 0.9167 | 11 | 12 | 2,540 | 314,121 |
2021-09-01 | 4.0 | 4 | 1 | 211.00 | 850.00 |
2021-06-01 | 1.625 | 13 | 8 | 2,422,374 | 4,818,458 |
2021-03-01 | 0.7857 | 11 | 14 | 75,207 | 29,473 |
2020-12-01 | 1.0 | 6 | 6 | 5,282 | 12,984 |
2020-09-01 | 0.8 | 8 | 10 | 922,070 | 1,842,376 |
2020-06-01 | 0.8235 | 14 | 17 | 13,868,853 | 27,726,965 |
2020-03-01 | 0.4091 | 9 | 22 | 65,493 | 26,629 |
2019-12-01 | 1.1667 | 7 | 6 | 12,802 | 24,930 |
2019-09-01 | 0.6 | 6 | 10 | 2,400,333 | 4,805,590 |
2019-06-01 | 1.5 | 6 | 4 | 4,563 | 3,260 |
2019-03-01 | 0.5 | 8 | 16 | 66,949 | 43,606 |
2018-12-01 | 1.3333 | 4 | 3 | 2,802 | 3,500 |
2018-09-01 | 0.6667 | 6 | 9 | 6,750,265 | 13,514,588 |
2018-06-01 | 2.3333 | 7 | 3 | 5,191 | 3,500 |
2018-03-01 | 0.8182 | 9 | 11 | 75,062 | 18,391 |
2017-09-01 | 1.0 | 3 | 3 | 243.00 | 3,805 |
2017-06-01 | 4.0 | 4 | 1 | 2,634 | 5,000 |
2017-03-01 | 0.9091 | 10 | 11 | 57,885 | 26,205 |
2016-09-01 | 5.0 | 5 | 1 | 47,719 | 10,000 |
2016-06-01 | 1.1111 | 10 | 9 | 9,017,973 | 18,002,710 |
2016-03-01 | 0.7778 | 7 | 9 | 56,362 | 42,722 |
2015-12-01 | 1.1429 | 8 | 7 | 12,195,175 | 24,000,360 |
2015-09-01 | 0.5455 | 6 | 11 | 48,450 | 105,362 |
2015-06-01 | 1.0 | 8 | 8 | 13,506,147 | 27,003,311 |
2015-03-01 | 2.0 | 4 | 2 | 8,320 | 1,179 |
2014-09-01 | 2.0 | 2 | 1 | 226.00 | 477.00 |
2014-06-01 | 2.0 | 4 | 2 | 4,934 | 5,481 |
2014-03-01 | 4.0 | 8 | 2 | 28,414 | 971.00 |
2013-09-01 | 0.6667 | 2 | 3 | 132.00 | 2,475 |
2013-06-01 | 2.0 | 4 | 2 | 2,412 | 975.00 |
2013-03-01 | 2.0 | 8 | 4 | 38,236 | 3,108 |
2012-06-01 | 2.5 | 10 | 4 | 40,769 | 46,018 |
2012-03-01 | 2.0 | 4 | 2 | 2,905 | 1,120 |
2011-09-01 | 4.0 | 4 | 1 | 1,874 | 16,622 |
2008-12-01 | 1.0 | 3 | 3 | 17,750 | 17,750 |
2007-12-01 | 5.6667 | 17 | 3 | 959,650 | 24,000 |
2007-03-01 | 0.75 | 3 | 4 | 75,000 | 350,000 |
2006-12-01 | 1.6667 | 5 | 3 | 464,250 | 60,750 |
2006-03-01 | 2.0 | 2 | 1 | 210,017 | 5,000 |
2005-12-01 | 3.3333 | 10 | 3 | 710,000 | 50,000 |
2005-06-01 | 1.0 | 1 | 1 | 10,000 | 10,000 |
2005-03-01 | 2.0 | 4 | 2 | 103,666 | 98,666 |
2004-12-01 | 11.0 | 11 | 1 | 644,500 | 9,500 |
2004-09-01 | 2.0 | 2 | 1 | 500,000 | 0.00 |
2002-12-01 | 1.0 | 1 | 1 | 5,000 | 25,000 |
Cencora Notable Stakeholders
A Cencora stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cencora often face trade-offs trying to please all of them. Cencora's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cencora's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
PharmD Mauch | CEO, President | Profile | |
John Chou | Ex CEO | Profile | |
Paul Szurek | President, Chief Executive Officer, Director | Profile | |
Robert Stuckey | Independent Chairman of the Board | Profile | |
Steven Collis | President Chairman | Profile | |
Maile Kaiser | Senior Vice President of Sales | Profile | |
Derek McCandless | Senior Vice President - Legal, General Counsel, Secretary | Profile | |
Juan Font | Senior Vice President - General Management | Profile | |
Brian Warren | Senior Vice President - Development and Product Engineering | Profile | |
RPh Nightengale | President Pharmacy | Profile | |
James Cleary | Executive CFO | Profile | |
Jeffrey Finnin | Chief Financial Officer | Profile | |
Richard Tremonte | EVP Pharmaceuticals | Profile | |
Steven Smith | Sr. VP of Sales and Marketing | Profile | |
David Wilson | Lead Independent Director | Profile | |
James Attwood | Independent Director | Profile | |
John Thompson | Independent Director | Profile | |
Jean Bua | Independent Director | Profile | |
Michael Koehler | Independent Director | Profile | |
Kelly Chambliss | Independent Director | Profile | |
Pawan Verma | Chief VP | Profile | |
Lazarus Krikorian | Chief VP | Profile | |
J Quinn | VP Treasurer | Profile | |
Michael Millegan | Independent Director | Profile | |
Elizabeth JD | Executive Officer | Profile | |
Bennett Murphy | Senior Relations | Profile | |
Elizabeth Campbell | Executive Officer | Profile | |
Silvana Battaglia | Executive Officer | Profile | |
Leslie Donato | Executive Officer | Profile | |
Aleksandra Krusko | Senior Vice President Information Technology | Profile | |
Anthony Hatzenbuehler | Senior Vice President Data Center Operations | Profile | |
Ann Anaya | Senior Officer | Profile | |
Gina Clark | Executive Officer | Profile | |
Jennifer Dubas | Senior Officer | Profile | |
Kathy Gaddes | Ex Officer | Profile | |
Patricia Higgins | Independent Director | Profile |
About Cencora Management Performance
The success or failure of an entity such as Cencora often depends on how effective the management is. Cencora management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cencora management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cencora management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.03 | 0.03 | |
Return On Capital Employed | 0.17 | 0.15 | |
Return On Assets | 0.02 | 0.02 | |
Return On Equity | 2.34 | 2.45 |
Cencora Workforce Analysis
Traditionally, organizations such as Cencora use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cencora within its industry.Cencora Manpower Efficiency
Return on Cencora Manpower
Revenue Per Employee | 6.4M | |
Revenue Per Executive | 8.2B | |
Net Income Per Employee | 33K | |
Net Income Per Executive | 42.2M |
Additional Tools for Cencora Stock Analysis
When running Cencora's price analysis, check to measure Cencora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cencora is operating at the current time. Most of Cencora's value examination focuses on studying past and present price action to predict the probability of Cencora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cencora's price. Additionally, you may evaluate how the addition of Cencora to your portfolios can decrease your overall portfolio volatility.